# Ypsomed evaluating production site in China

Ypsomed is evaluating possible production sites in China to establish local manufacturing of injection pens, investing in fully automated production lines from Europe, to serve the growing Chinese diabetes market.

- Type: New facility
- Announced: 2022-07-11
- Where: China, China
- Status: announced
- Products: injection pens, ServoPen, YpsoPen, UnoPen, YpsoMate
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Ypsomed](https://endata.com/companies/9625.md)

## Sources

- [ypsomed.com](https://www.ypsomed.com/en/news-insights/company-stories/company-stories-detail-page/ypsomed-in-china-963), 2022-07-11: "We are currently evaluating possible production sites in order to be able to produce locally in the future and supply the Chinese market directly"

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.